Astrana Health, Inc. (ASTH)
Automate Your Wheel Strategy on ASTH
With Tiblio's Option Bot, you can configure your own wheel strategy including ASTH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ASTH
- Rev/Share 46.4317
- Book/Share 1.1293
- PB 21.1289
- Debt/Equity 0.867
- CurrentRatio 0.7915
- ROIC 0.0899
- MktCap 1191303554.0
- FreeCF/Share 1.1385
- PFCF 21.5871
- PE 33.0375
- Debt/Assets 0.0547
- DivYield 0
- ROE 0.0651
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | ASTH | Barclays | -- | Equal Weight | -- | $36 | April 1, 2025 |
| Initiation | ASTH | TD Cowen | -- | Buy | -- | $66 | Oct. 14, 2024 |
| Initiation | ASTH | KeyBanc Capital Markets | -- | Sector Weight | -- | -- | Oct. 11, 2024 |
News
ASTH vs. CHE: Which Stock Is the Better Value Option?
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Astrana Health, Inc. (ASTH) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Wall Street Analysts Think Astrana Health, Inc. (ASTH) Could Surge 97.29%: Read This Before Placing a Bet
Published: July 15, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 97.3% in Astrana Health, Inc. (ASTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
All You Need to Know About Astrana Health, Inc. (ASTH) Rating Upgrade to Strong Buy
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Astrana Health, Inc. (ASTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Read More
ASTH or CHE: Which Is the Better Value Stock Right Now?
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Astrana Health, Inc. (ASTH) or Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Astrana Health Strengthens Leadership Team to Scale AI-Enabled Healthcare Delivery Platform for All
Published: June 03, 2025 by: PRNewsWire
Sentiment: Neutral
ALHAMBRA, Calif. , June 3, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced several key additions to its senior leadership team.
Read More
Astrana Health, Inc. (ASTH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Astrana Health, Inc. (ASTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Astrana Health, Inc. (ASTH) Q4 2024 Earnings Call Transcript
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Neutral
Astrana Health, Inc. (NASDAQ:ASTH ) Q4 2024 Earnings Conference Call February 27, 2025 5:30 PM ET Company Participants Brandon Sim - President & CEO Chan Basho - Chief Operating & Financial Officer Conference Call Participants Ryan Daniels - William Blair Michael Ha - Baird Jailendra Singh - Truist Securities Ryan Langston - TD Cowen Adam Ron - Bank of America Craig Jones – Stifel Brooks O'Neil - Lake Street Capital David Larsen - BTIG Matt Gilmore - KeyBanc Capital Gene Mannheimer - Freedom Capital Markets Operator Good day, everyone, and welcome to today's Astrana Health Fourth Quarter and Full Year …
Read More
Astrana Health, Inc. (ASTH) Reports Q4 Loss, Tops Revenue Estimates
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Negative
Astrana Health, Inc. (ASTH) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of $0.09. This compares to earnings of $0.26 per share a year ago.
Read More
Astrana Health, Inc. Schedules 2024 Fourth Quarter and Full Year Financial Results Release and Conference Call
Published: February 17, 2025 by: PRNewsWire
Sentiment: Neutral
ALHAMBRA, Calif. , Feb. 17, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024, after the close of the stock market on Thursday, February 27, 2025.
Read More
About Astrana Health, Inc. (ASTH)
- IPO Date 2009-03-11
- Website https://www.astranahealth.com
- Industry Medical - Care Facilities
- CEO Brandon K. Sim
- Employees 1900